{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:52:43Z","timestamp":1787161963405,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,18]]},"DOI":"10.7759\/cureus.75954","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:21:02Z","timestamp":1734524462000},"source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Bandar A","family":"Almabruk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A","family":"Bajafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed N","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A","family":"Al-Zahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naif M","family":"Albishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafeef","family":"Aljarwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola A","family":"Aljaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama I","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turki S","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almas S","family":"Alsolami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joud K","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.30574\/wjarr.2024.22.1.1130","article-title":"The irritable bowel syndrome (IBS): understanding its types, prevalence, and treatment options","volume":"22","author":"Porwal A","year":"2024","unstructured":"Porwal A, Bhagwat G, Sawarkar J, Kamble P. The irritable bowel syndrome (IBS): understanding its types, prevalence, and treatment options. World J Adv Res Rev. 2024, 22:720-8. 10.30574\/wjarr.2024.22.1.1130","journal-title":"World J Adv Res Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13030-024-00309-5","article-title":"Work-related problems and the psychosocial characteristics of individuals with irritable bowel syndrome: an updated literature review","volume":"18","author":"Sugaya N","year":"2024","unstructured":"Sugaya N. Work-related problems and the psychosocial characteristics of individuals with irritable bowel syndrome: an updated literature review. Biopsychosoc Med. 2024, 18:12. 10.1186\/s13030-024-00309-5","journal-title":"Biopsychosoc Med"},{"key":"ref3","article-title":"Epidemiology of irritable bowel syndrome: a systematic review and meta-analysis","volume":"2","author":"Li C","year":"2024","unstructured":"Li C, Ying Y, Zheng Y, Li X, Lan L. Epidemiology of irritable bowel syndrome: a systematic review and meta-analysis. Epidemiol Public Health. 2024, 2:1034.","journal-title":"Epidemiol Public Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063514","article-title":"Multi-omics analysis of gut microbiota and host transcriptomics reveal dysregulated immune response and metabolism in young adults with irritable bowel syndrome","volume":"25","author":"Chen J","year":"2024","unstructured":"Chen J, Zhao T, Li H, et al.. Multi-omics analysis of gut microbiota and host transcriptomics reveal dysregulated immune response and metabolism in young adults with irritable bowel syndrome. Int J Mol Sci. 2024, 25:3514. 10.3390\/ijms25063514","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102369","article-title":"Gut dysbiosis in irritable bowel syndrome: a narrative review on correlation with disease subtypes and novel therapeutic implications","volume":"11","author":"Napolitano M","year":"2023","unstructured":"Napolitano M, Fasulo E, Ungaro F, Massimino L, Sinagra E, Danese S, Mandarino FV. Gut dysbiosis in irritable bowel syndrome: a narrative review on correlation with disease subtypes and novel therapeutic implications. Microorganisms. 2023, 11:2369. 10.3390\/microorganisms11102369","journal-title":"Microorganisms"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/0126660822304321240520075036","article-title":"Unveiling the therapeutic potential of modern probiotics in addressing neurodegenerative disorders: a comprehensive exploration, review and future perspectives on intervention strategies","volume":"20","author":"Sharma H","year":"2024","unstructured":"Sharma H, Pathak R, Biswas D. Unveiling the therapeutic potential of modern probiotics in addressing neurodegenerative disorders: a comprehensive exploration, review and future perspectives on intervention strategies. Curr Psychiatry Res Rev. 2024, 20:1-25. 10.2174\/0126660822304321240520075036","journal-title":"Curr Psychiatry Res Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i15.2096","article-title":"Probiotics: shaping the gut immunological responses","volume":"30","author":"Filidou E","year":"2024","unstructured":"Filidou E, Kandilogiannakis L, Shrewsbury A, Kolios G, Kotzampassi K. Probiotics: shaping the gut immunological responses. World J Gastroenterol. 2024, 30:2096-108. 10.3748\/wjg.v30.i15.2096","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2024.01.003","article-title":"Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome","volume":"71","author":"Ruiz-S\u00e1nchez C","year":"2024","unstructured":"Ruiz-S\u00e1nchez C, Escudero-L\u00f3pez B, Fern\u00e1ndez-Pach\u00f3n MS. Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome. Endocrinol Diabetes Nutr (Engl Ed). 2024, 71:19-30. 10.1016\/j.endien.2024.01.003","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.07.018","article-title":"Efficacy of probiotics in irritable bowel syndrome: systematic review and meta-analysis","volume":"165","author":"Goodoory VC","year":"2023","unstructured":"Goodoory VC, Khasawneh M, Black CJ, Quigley EM, Moayyedi P, Ford AC. Efficacy of probiotics in irritable bowel syndrome: systematic review and meta-analysis. Gastroenterology. 2023, 165:1206-18. 10.1053\/j.gastro.2023.07.018","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001758","article-title":"Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"72","author":"Zhang WX","year":"2023","unstructured":"Zhang WX, Shi LB, Zhou MS, Wu J, Shi HY. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials. J Med Microbiol. 2023, 72:10.1099\/jmm.0.001758","journal-title":"J Med Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu15173856","article-title":"Outcome-specific efficacy of different probiotic strains and mixtures in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"15","author":"Xie P","year":"2023","unstructured":"Xie P, Luo M, Deng X, Fan J, Xiong L. Outcome-specific efficacy of different probiotic strains and mixtures in irritable bowel syndrome: a systematic review and network meta-analysis. Nutrients. 2023, 15:3856. 10.3390\/nu15173856","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000094","article-title":"Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial","volume":"26","author":"Abbas Z","year":"2014","unstructured":"Abbas Z, Yakoob J, Jafri W, et al.. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial. Eur J Gastroenterol Hepatol. 2014, 26:630-9. 10.1097\/MEG.0000000000000094","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.11.007","article-title":"A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome","volume":"47","author":"Pineton de Chambrun G","year":"2015","unstructured":"Pineton de Chambrun G, Neut C, Chau A, Cazaubiel M, Pelerin F, Justen P, Desreumaux P. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome. Dig Liver Dis. 2015, 47:119-24. 10.1016\/j.dld.2014.11.007","journal-title":"Dig Liver Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/abr.abr_216_17","article-title":"Effect of probiotic administration immediately and 1 month after colonoscopy in diarrhea-predominant irritable bowel syndrome patients","volume":"7","author":"Khodadoostan M","year":"2018","unstructured":"Khodadoostan M, Shavakhi A, Sherafat Z, Shavakhi A. Effect of probiotic administration immediately and 1 month after colonoscopy in diarrhea-predominant irritable bowel syndrome patients. Adv Biomed Res. 2018, 7:94. 10.4103\/abr.abr_216_17","journal-title":"Adv Biomed Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10068-017-0296-7","article-title":"Effect of Lactobacillus gasseri BNR17 on irritable bowel syndrome: a randomized, double-blind, placebo-controlled, dose-finding trial","volume":"27","author":"Kim JY","year":"2018","unstructured":"Kim JY, Park YJ, Lee HJ, Park MY, Kwon O. Effect of Lactobacillus gasseri BNR17 on irritable bowel syndrome: a randomized, double-blind, placebo-controlled, dose-finding trial. Food Sci Biotechnol. 2018, 27:853-7. 10.1007\/s10068-017-0296-7","journal-title":"Food Sci Biotechnol"},{"key":"ref17","article-title":"Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating","volume":"17","author":"Jafari E","year":"2014","unstructured":"Jafari E, Vahedi H, Merat S, Momtahen S, Riahi A. Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating. Arch Iran Med. 2014, 17:466-70.","journal-title":"Arch Iran Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i26.8709","article-title":"I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life","volume":"20","author":"Lorenzo-Z\u00fa\u00f1iga V","year":"2014","unstructured":"Lorenzo-Z\u00fa\u00f1iga V, Llop E, Su\u00e1rez C, Alvarez B, Abreu L, Espadaler J, Serra J. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol. 2014, 20:8709-16. 10.3748\/wjg.v20.i26.8709","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12320","article-title":"Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients","volume":"26","author":"Ludidi S","year":"2014","unstructured":"Ludidi S, Jonkers DM, Koning CJ, et al.. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients. Neurogastroenterol Motil. 2014, 26:705-14. 10.1111\/nmo.12320","journal-title":"Neurogastroenterol Motil"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i43.16215","article-title":"Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome","volume":"20","author":"Pedersen N","year":"2014","unstructured":"Pedersen N, Andersen NN, V\u00e9gh Z, et al.. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol. 2014, 20:16215-26. 10.3748\/wjg.v20.i43.16215","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.135157","article-title":"The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: a randomized placebo-controlled trial","volume":"3","author":"Shavakhi A","year":"2014","unstructured":"Shavakhi A, Minakari M, Farzamnia S, et al.. The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: a randomized placebo-controlled trial. Adv Biomed Res. 2014, 3:140. 10.4103\/2277-9175.135157","journal-title":"Adv Biomed Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12787","article-title":"Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study","volume":"40","author":"Sisson G","year":"2014","unstructured":"Sisson G, Ayis S, Sherwood RA, Bjarnason I. Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study. Aliment Pharmacol Ther. 2014, 40:51-62. 10.1111\/apt.12787","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2014.02.010","article-title":"Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome","volume":"30","author":"Stevenson C","year":"2014","unstructured":"Stevenson C, Blaauw R, Fredericks E, Visser J, Roux S. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome. Nutrition. 2014, 30:1151-7. 10.1016\/j.nut.2014.02.010","journal-title":"Nutrition"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12322","article-title":"Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial","volume":"29","author":"Yoon JS","year":"2014","unstructured":"Yoon JS, Sohn W, Lee OY, et al.. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol. 2014, 29:52-9. 10.1111\/jgh.12322","journal-title":"J Gastroenterol Hepatol"},{"key":"ref25","article-title":"Efficacy of probiotic Escherichia coli Nissle 1917 in patients with irritable bowel syndrome: a double blind placebo-controlled randomized trial","volume":"47","author":"Faghihi AH","year":"2015","unstructured":"Faghihi AH, Agah S, Masoudi M, Ghafoori SM, Eshraghi A. Efficacy of probiotic Escherichia coli Nissle 1917 in patients with irritable bowel syndrome: a double blind placebo-controlled randomized trial. Acta Med Indones. 2015, 47:201-8.","journal-title":"Acta Med Indones"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.15-14","article-title":"Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Yoon H","year":"2015","unstructured":"Yoon H, Park YS, Lee DH, Seo JG, Shin CM, Kim N. Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Biochem Nutr. 2015, 57:129-34. 10.3164\/jcbn.15-14","journal-title":"J Clin Biochem Nutr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i48.10631","article-title":"Irritable bowel syndrome symptom severity improves equally with probiotic and placebo","volume":"22","author":"Lyra A","year":"2016","unstructured":"Lyra A, Hillil\u00e4 M, Huttunen T, et al.. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol. 2016, 22:10631-42. 10.3748\/wjg.v22.i48.10631","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-016-0140-6","article-title":"Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant irritable bowel syndrome: a double blind randomized placebo controlled pilot clinical study","volume":"15","author":"Majeed M","year":"2016","unstructured":"Majeed M, Nagabhushanam K, Natarajan S, et al.. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant irritable bowel syndrome: a double blind randomized placebo controlled pilot clinical study. Nutr J. 2016, 15:21. 10.1186\/s12937-016-0140-6","journal-title":"Nutr J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4740907","article-title":"A randomized, double-blind, placebo-controlled trial: the efficacy of multispecies probiotic supplementation in alleviating symptoms of irritable bowel syndrome associated with constipation","volume":"2016","author":"Mezzasalma V","year":"2016","unstructured":"Mezzasalma V, Manfrini E, Ferri E, et al.. A randomized, double-blind, placebo-controlled trial: the efficacy of multispecies probiotic supplementation in alleviating symptoms of irritable bowel syndrome associated with constipation. Biomed Res Int. 2016, 2016:4740907. 10.1155\/2016\/4740907","journal-title":"Biomed Res Int"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/2050640615602571","article-title":"Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation","volume":"4","author":"Spiller R","year":"2016","unstructured":"Spiller R, P\u00e9lerin F, Cayzeele Decherf A, Maudet C, Housez B, Cazaubiel M, J\u00fcsten P. Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterol J. 2016, 4:353-62. 10.1177\/2050640615602571","journal-title":"United European Gastroenterol J"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000484","article-title":"Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome","volume":"28","author":"Thijssen AY","year":"2016","unstructured":"Thijssen AY, Clemens CH, Vankerckhoven V, Goossens H, Jonkers DM, Masclee AA. Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2016, 28:8-14. 10.1097\/MEG.0000000000000484","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13037","article-title":"A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS","volume":"29","author":"Hod K","year":"2017","unstructured":"Hod K, Sperber AD, Ron Y, et al.. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS. Neurogastroenterol Motil. 2017, 29:e13037. 10.1111\/nmo.13037","journal-title":"Neurogastroenterol Motil"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-018-0788-9","article-title":"A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult\u00ae) in the management of diarrhea-predominant irritable bowel syndrome","volume":"18","author":"Ishaque SM","year":"2018","unstructured":"Ishaque SM, Khosruzzaman SM, Ahmed DS, Sah MP. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult\u00ae) in the management of diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol. 2018, 18:71. 10.1186\/s12876-018-0788-9","journal-title":"BMC Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3920\/BM2017.0105","article-title":"Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study","volume":"9","author":"Preston K","year":"2018","unstructured":"Preston K, Krumian R, Hattner J, de Montigny D, Stewart M, Gaddam S. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. Benef Microbes. 2018, 9:697-706. 10.3920\/BM2017.0105","journal-title":"Benef Microbes"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21241-z","article-title":"The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial","volume":"8","author":"Sun YY","year":"2018","unstructured":"Sun YY, Li M, Li YY, et al.. The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Sci Rep. 2018, 8:2964. 10.1038\/s41598-018-21241-z","journal-title":"Sci Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2023.100721","article-title":"Methods of determining irritable bowel syndrome and efficiency of probiotics in treatment: a review","volume":"99","author":"Ahlawat GM","year":"2023","unstructured":"Ahlawat GM, Singh PK. Methods of determining irritable bowel syndrome and efficiency of probiotics in treatment: a review. Curr Ther Res Clin Exp. 2023, 99:100721. 10.1016\/j.curtheres.2023.100721","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2024.04.202690","article-title":"Features of the effect of a probiotic, containing Lactobacillus and Bifidobacterium on the intestinal microbiota and clinical symptoms of irritable bowel syndrome. (Article in Russian)","volume":"96","author":"Khalaidzheva KN","year":"2024","unstructured":"Khalaidzheva KN, Nikitina NV, Astrashkova OV, Drozdov VN, Melkonyan GG, Shikh EV. Features of the effect of a probiotic, containing Lactobacillus and Bifidobacterium on the intestinal microbiota and clinical symptoms of irritable bowel syndrome. (Article in Russian). Terapevticheskii Arkhiv. 2024, 96:356-63. 10.26442\/00403660.2024.04.202690","journal-title":"Terapevticheskii Arkhiv"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24240","article-title":"Probiotics in irritable bowel syndrome: a review of their therapeutic role","volume":"14","author":"Satish Kumar L","year":"2022","unstructured":"Satish Kumar L, Pugalenthi LS, Ahmad M, Reddy S, Barkhane Z, Elmadi J. Probiotics in irritable bowel syndrome: a review of their therapeutic role. Cureus. 2022, 14:e24240. 10.7759\/cureus.24240","journal-title":"Cureus"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/nu14122482","article-title":"Effectiveness and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 randomized controlled trials","volume":"14","author":"Shang X","year":"2022","unstructured":"Shang X, E FF, Guo KL, et al.. Effectiveness and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 randomized controlled trials. Nutrients. 2022, 14:2482. 10.3390\/nu14122482","journal-title":"Nutrients"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/nu14132689","article-title":"Evaluating the efficacy of probiotics in IBS treatment using a systematic review of clinical trials and multi-criteria decision analysis","volume":"14","author":"Ceccherini C","year":"2022","unstructured":"Ceccherini C, Daniotti S, Bearzi C, Re I. Evaluating the efficacy of probiotics in IBS treatment using a systematic review of clinical trials and multi-criteria decision analysis. Nutrients. 2022, 14:2689. 10.3390\/nu14132689","journal-title":"Nutrients"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027376","article-title":"Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol","volume":"9","author":"Yang M","year":"2019","unstructured":"Yang M, Yu Y, Lei PG, Yuan J. Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol. BMJ Open. 2019, 9:e027376. 10.1136\/bmjopen-2018-027376","journal-title":"BMJ Open"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209205","article-title":"Choosing an appropriate probiotic product for your patient: an evidence-based practical guide","volume":"13","author":"Sniffen JC","year":"2018","unstructured":"Sniffen JC, McFarland LV, Evans CT, Goldstein EJ. Choosing an appropriate probiotic product for your patient: an evidence-based practical guide. PLoS One. 2018, 13:e0209205. 10.1371\/journal.pone.0209205","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00124","article-title":"Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis","volume":"5","author":"McFarland LV","year":"2018","unstructured":"McFarland LV, Evans CT, Goldstein EJ. Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis. Front Med (Lausanne). 2018, 5:124. 10.3389\/fmed.2018.00124","journal-title":"Front Med (Lausanne)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/9781119804055.ch2","article-title":"Psychobiotics, a special type of probiotics, and their potential molecular mechanisms to ameliorate symptoms of stress and anxiety","author":"Hernandez-Barrueta T","year":"2022","unstructured":"Hernandez-Barrueta T. Psychobiotics, a special type of probiotics, and their potential molecular mechanisms to ameliorate symptoms of stress and anxiety. Molecular Mechanisms of Functional Food. Campos-Vega R, Oomah BD (ed): Wiley, New York, NY; 2022. 28-56. 10.1002\/9781119804055.ch2"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.10044","article-title":"Use of probiotics in treating psychiatric and neurological disorders","volume":"74","author":"Fatima SM","year":"2024","unstructured":"Fatima SM, Khan A, Asghar B. Use of probiotics in treating psychiatric and neurological disorders. J Pak Med Assoc. 2024, 74:202. 10.47391\/JPMA.10044","journal-title":"J Pak Med Assoc"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00332","article-title":"Efficacy and safety of probiotics in irritable bowel syndrome: a systematic review and meta-analysis","volume":"11","author":"Li B","year":"2020","unstructured":"Li B, Liang L, Deng H, Guo J, Shu H, Zhang L. Efficacy and safety of probiotics in irritable bowel syndrome: a systematic review and meta-analysis. Front Pharmacol. 2020, 11:332. 10.3389\/fphar.2020.00332","journal-title":"Front Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326089-efficacy-of-probiotics-in-the-management-of-irritable-bowel-syndrome-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:21:05Z","timestamp":1734524465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326089-efficacy-of-probiotics-in-the-management-of-irritable-bowel-syndrome-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.75954","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,18]]}}}